Marta Garcia-Mascarenas

Santiago De Compostela, GA, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Understanding Late-Stage Clinical Trial Failure in Multiple Sclerosis: Insights from ClinicalTrials.gov.

Understanding Late-Stage Clinical Trial Failure in Multiple Sclerosis: Insights from ClinicalTrials.gov.

Journal: Neuroepidemiology

Published: January 21, 2026

Determinants of clinical trial failure in multiple sclerosis: insights from ClinicalTrials.gov.

Determinants of clinical trial failure in multiple sclerosis: insights from ClinicalTrials.gov.

Journal: Research square

Published: September 26, 2025

Distortion in the Communication of Nonsignificant Primary Outcomes: The Spin Strategy in Multiple Sclerosis Trials.

Distortion in the Communication of Nonsignificant Primary Outcomes: The Spin Strategy in Multiple Sclerosis Trials.

Journal: Annals of neurology

Published: June 22, 2025

Prevalence and characterisation of energy drink consumption in Europe: a systematic review.

Prevalence and characterisation of energy drink consumption in Europe: a systematic review.

Journal: Public health nutrition

Published: June 03, 2025

Silent protocol modifications in multiple sclerosis clinical trials: a registry-based cross-sectional study.

Silent protocol modifications in multiple sclerosis clinical trials: a registry-based cross-sectional study.

Journal: Therapeutic advances in neurological disorders

Published: January 21, 2025

Discrepancies in the results reported for multiple sclerosis clinical trials: A comparison between ClinicalTrials.gov and peer-reviewed journals.

Discrepancies in the results reported for multiple sclerosis clinical trials: A comparison between ClinicalTrials.gov and peer-reviewed journals.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: August 27, 2024

Consumption of hypnosedatives in Spain: characterization and time trends, 2005-2022.

Consumption of hypnosedatives in Spain: characterization and time trends, 2005-2022.

Journal: Gaceta sanitaria

Published: July 16, 2024

Recommendations for the critical reading of clinical trials on disease-modifying drugs for multiple sclerosis.

Recommendations for the critical reading of clinical trials on disease-modifying drugs for multiple sclerosis.

Journal: Neurologia

Published: July 12, 2023

Best practices in phase III clinical trials on DMTs for multiple sclerosis: a systematic analysis and appraisal of published trials.

Best practices in phase III clinical trials on DMTs for multiple sclerosis: a systematic analysis and appraisal of published trials.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: April 25, 2023

Showing 1-9 of 9

Last Updated: 09/26/2026